To Evaluate the Safety, Tolerability and Pharmacokinetic Properties of DWRX2003
Clinical trial NCT04592835 · UNKNOWN
Trial details
- NCT number
- NCT04592835
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-19
- Primary completion
- 2020-12-13
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.